Lisa Bellm, M.I.M.
Clinical Outcomes Consultant
IntraBiotics Pharmaceuticals,
Inc
1255 Terra Bella Avenue
Mountain View,CA 94043
415-346-7290
650-969-0663 (fax)
bellm@intrabiotics.com
Lisa A. Bellm received her bachelor's degree from Bowling Green State
University in Bowling Green, Ohio and her master's degree in international
management from the American Graduate School of International Management
in Phoenix, Arizona. Ms. Bellm has worked in the biopharmaceutical
industry for thirteen years in several positions in the areas of commercial
development and outcomes research. She has worked for both large
pharmaceutical companies including Johnson & Johnson and for smaller
biotechnology firms. She began working for IntraBiotics Pharmaceuticals
in February 1998 and assumed responsibility for the outcomes research
program in November 1999. At IntraBiotics, Ms. Bellm has managed
several studies evaluating the health and economic impact of oral
mucositis, including a collaborative study with the International
Bone Marrow Transplant Registry, and has been a co-author on a number
of abstracts and papers. She has also played a lead role in
the formation of industry-government-academic collaborations over
the design and conduct of studies. She is currently managing
the outcomes research effort for three clinical programs at IntraBiotics
and is a member of two infectious diseases outcomes scientific advisory
groups.
Douglas D. Bradham, Ph.D.
Associate Professor
University of Maryland Medical School
Department of Epidemiology and Preventive Medicine
Director, VISN 5 HSR&D Center
Baltimore VAMC (151H)
10 North Greene Street
Baltimore, MD 21201
410-605-7116
410-605-7738 (fax)
douglas.bradham@med.va.gov
Douglas D. Bradham, Dr.P.H., Associate Professor
Department of Epidemiology and Preventive Medicine,
Division of Healthcare Outcomes Research,
University of Maryland at Baltimore, School of Medicine
and
Director, Veterans Affairs Capital Network (VISN 5) HSR&D Center
and
Health Economist, Veterans Affairs Cooperative Studies Program,
Perry Point, Maryland
Douglas D. Bradham, Dr. P.H. was trained in Health Economics and
Health Services Research at the University of North Carolina, at Chapel
Hill. He is experienced in health care systems from several
perspectives including that of the manager, evaluator, researcher
and policy analyst. Bradham has taught graduate courses in health
economics, health policy, health services research, long-term care
and health care marketing and management. He has published over
54 articles in areas of health services research, health care management,
outcomes research, rural health care and health economics. Recent
work include: providing economic analyses for clinical trials investigating
medical, surgical and home health interventions; the assessment of
new technology and telemedicine; and the economics of secondary prevention
and health promotion in adults with chronic disease and the public
costs of adolescent pregnancy.
Dr. Bradham is the Director of the HSR&D Center for the Capitol
Network, which is one of the regional Veterans’ Integrated Service
Networks (VISN 5). He also serves as a Health Economist for
the Veterans Healthcare Administration (VHA) Cooperative Studies Program
(CSP), which is a multi-site clinical trials research system.
He is currently the Co-Principal Investigator of a three-year VHA
HSR&D project investigating the outcomes of Disease Management
and Educational Intervention Outcomes in High-Risk Diabetics, which
is a $3.1 million dollar clinical demonstration project and PI for
an Evaluation of Home and Community Healthcare and Telehealth Coordination
Services in Florida.
During his academic career Dr. Bradham has served the scientific
community as a member of the Technical Advisory Panel to the Institute
of Medicine’s Committee on Evaluating Telemedicine and the National
Cancer Institute’s Steering Committee for Virtual Colonoscopy.
He has served as a reviewer and editorial board member for several
health services research journals, including: The American Journal
of Public Health, The Journal of Health Services Research, The Journal
of Rural Health, The Journal of Women’s Health, Obstetric and Gynecology,
The Journal of the American Geriatrics Association, The Journal of
National Cancer Institute and The Carolina Health Services Review.
Several of his publications have been selected for national attention
including inclusion in: the 1995 AMA’s Scientific Writer’s Conference
and the 1995 Yearbook of Endocrinology.
Dr. Bradham has served state and national groups in the role of health
policy analyst and adviser. He served the State of Florida as
an advisor to the Florida Legislature in the 1980s. Bradham
was appointed by North Carolina Governor James Hunt to the Financing
Task Force of the North Carolina Health Planning Commission’s Health
Care Reform Study in 1994. Between 1992 and 2000 he was appointed
by the U.S. Secretary of Veterans Affairs to the Scientific Merit
Review Board for the Department of Veterans Affairs for Health Services
Research and Developments. He also serves on the Nursing Research
Initiatives Review Board for the VHA HSR&D Service.
Mark Callahan, M.D.
Director of Outcomes Research
Chief, Division of Outcomes and Medical Effectiveness
New York Presbyterian Healthcare Network
Weill Medical College of Cornell University
525 East 68th Street, Box 572
New York, NY 10021
212 -746-2874
212- 746-8698 (fax)
mcallah@med.cornell.edu
Mark Callahan, MD is Chief of the Division of Outcomes and Effectiveness
Research and Assistant Professor of Public Health and Medicine in
the Department of Public Health at Weill Medical College of Cornell
University. Dr. Callahan is also Director of Outcomes Research
for the New York Presbyterian Healthcare Network, a developing integrated
delivery system in the New York metropolitan region.
Dr. Callahan graduated from the University of Virginia, and received
his MD from the University of North Carolina. His internship
and residency were in Internal Medicine at Stanford University Medical
Center, where he also was a Robert Wood Johnson Clinical Scholar.
Dr. Callahan was Chief of Medicine at the VA Livermore for three years
between his residency and fellowship at Stanford. Dr. Callahan’s
research interests focus on quality of care, changing physician and
hospital behavior, and on the organization of health care delivery
systems.
Ralph L. Cordell, Ph.D.
Acting Section Chief
Health Quality Research Section
Healthcare Outcomes Branch
Divison of Health Quality Promotion and Infection Prevention
Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333
404-639-6478
404-639-6483 (fax)
rzc4@cdc.gov
Ralph Cordell is Acting Section Chief, Quality Research Section,
Division of Healthcare Quality Promotion (formerly Hospital Infections
Program), National Center for Infectious Diseases, Centers for Disease
Control and Prevention, Atlanta, Georgia. He received has Bachelors
and Masters degrees in Zoology from Southern Illinois University in
Carbondale and his PhD in Epidemiology from the University of Illinois
School of Public Health in Chicago. He worked as a Microbiologist
with the Illinois Department of Public Health Virology Section and
served as the Director of the Communicable Disease Control Division,
Cook County Department of Public Health in northeastern Illinois.
While there, he started the AIDS/HIV program and conducted control
activities in conjunction with the 1985 outbreak of milkborne salmonella.
He came to CDC in 1992 and worked in the area of child care health
and safety, participating in the 1993 outbreak of cryptosporidiosis
in Milwaukee, serving as consulting editor for the ABC's of Safe and
Healthy Children and conducting research in the area of infectious
disease epidemiology in child care settings. His activities
moved from child care to health care and he is currently working in
the area of attributable cost
and outcomes due to healthcare-associated infections and antimicrobial
infections. His research interests include epidemiologic methods,
applied epidemiology, and infectious disease prevention and control.
Elamin H. Elbasha, Ph.D.
Economist
Epidemiology Program Office
Division of Prevention Research and Analytic Methods,
Prevention Effectiveness Branch
Centers for Disease Control and Prevention
Koger Williams Building
2877 Brandywine Rd, MS K73
Atlanta, GA 30341
770-488-8196
770-488-8464 (fax)
ebe4@cdc.gov
Elamin Elbasha is a health economist in the Prevention Effectiveness
Branch, Division of Prevention Research and Analytic Methods, Epidemiology
Program Office, CDC. His research interests include assessment of
the burden of diseases, the cost-effectiveness and cost-benefits of
various public health interventions, analysis of economic policies
that impact public health, and integration of economic analysis and
methods into epidemiologic models and data.
W. Dana Flanders, M.D., M.P.H.
Professor
Department of Epidemiology
Rollins School of Public Health
1518 Clifton Rd., Rm. 464
Atlanta, GA 30322
wflande@sph.emory.edu
Curtis S. Florence, Ph.D.
Assistant Professor
Department of Health Policy and Management
Rollins School of Public Health
Emory University
Atlanta, GA 30322
404-727-2818
cfloren@sph.emory.edu
Curtis S. Florence, Ph.D. is an Assistant Professor in the Department
of Health Policy and Management at the Rollins School of Public Health
of Emory University. He received his doctorate in economics
from the University of North Carolina at Chapel Hill. His research
interests include insurance trends and the uninsured, the relationship
between employment and health insurance coverage, market-based reform
for private and public insurance, and the effect of managed care on
insurance coverage and health care delivery. His work has appeared
in journals such as Health Affairs and Inquiry.
Victoria J. Fraser, M.D.
Washington University School of Medicine
660 South Euclid Avenue
St. Louis, MO 63110
314-454-8272
314-454-5392 (fax)
vfraser@imgate.wustl.edu
Gina Haida <GHAIDA@im.wustl.edu>
Victoria J. Fraser M.D. is an associate professor of medicine at
Washington University School of Medicine. She is the medical director
of Infection Control for BJC Health System. She received her bachelor’s
degree from William Woods College in Fulton Missouri and her medical
degree from the University of Missouri in Columbia Missouri.
Dr. Fraser’s research interests involve infectious risks to health
care workers and implementing interventions to minimize those risks,
the epidemiology of nosocomial infections and implementation of interventions
to mimimize infection rates, risk factors and outcomes of nosocomial
infections (including costs), and the impact of antibiotic cycling
on the development of antibiotic resistance.
Thomas F. Goss, Pharm.D.
Vice President
Covance Health Economics
and Outcomes Services, Inc.
9801 Washingtonian Boulevard, 9th Floor
Gaithersburg, MD 20878-5355
240-632-3224
240-632-3225 (fax)
tom.goss@covance.com
Janice Spillan <janice.donohue@Covance.Com>
Thomas Goss is a vice president at Covance Health Economics and Outcomes
Services Inc. who directs and manages outcomes research studies.
Tom’s research experience includes patient-based assessment (including
health-related quality-of-life, patient preference, and patient satisfaction
studies) and health economic evaluations (including prospective economic
trials, and decision analysis models). He also directs and manages
outcomes studies to evaluate disease management programs for use in
managed care organizations.
Before joining Covance, Dr. Goss was director of outcomes research
at the Clinical Pharmacokinetics Laboratory at the State University
of New York at Buffalo and Millard Fillmore Hospital. While
at the University, he developed a research program designed to incorporate
outcomes studies into Phase III and post-marketing clinical trials.
Before that, he was a medical surveillance and communications associate
at Procter and Gamble Pharmaceuticals.
Dr. Goss is a member of the American College of Clinical Pharmacy
Outcomes and Economics Practice Research Network and the International
Society of Pharmacoeconomics and Outcomes Research.
Dr. Goss received a Pharm.D. from the State University of New York
at Buffalo and a B.S. from the Albany College of Pharmacy, and completed
a postdoctoral fellowship in pharmacoepidemiology and outcomes research
at the State University of New York at Buffalo Clinical Pharmacokinetics
Laboratory. During his fellowship Dr. Goss completed graduate
coursework in epidemiology.
David H. Howard , Ph.D.
Department of Health Policy and Management
Rollins School of Public Health
Emory University
1518 Clifton Rd, Rm. 610
Atlanta, GA 30322
401-727-3907
dhhoward@sph.emory.edu
David Howard is an Assistant Professor of Health Economics at the
Rollins School of Public Health of Emory University. His research
examines the regulation and industrial organization of health care
markets. Specific research topics include the allocation of organs
to transplant patients, the organization and design of health insurance
markets, and the use of antibiotics in light of the growing problem
of antibiotic resistance. David received his doctorate this year from
Harvard University and his BA from Vassar College.
Dr. Howard's homepage.
Ramanan Laxminarayan, Ph.D., M.P.H.
Fellow
Resources for the Future
1616 P St. NW
Washington, DC 20036
202-328-5085
202-939-3460 (fax)
Ramanan@rff.org
Education: Ph.D., Economics, University of Washington, Seattle, 1999
M.P.H, Epidemiology, University of Washington, Seattle, 1999
Bachelor of Engineering (Instrumentation), Birla Institute of Technology
& Science, Pilani, India, 1992
Professional Experience:
1999-present Fellow, Energy and Natural Resources Division, Resources
for the Future
1994-1999 Instructor, University of Washington: Introductory and Intermediate
Macroeconomics, and Microeconomics
Ramanan Laxminarayan is a fellow in the Energy and Natural Resources
Division at Resources for the Future (RFF). Laxminarayan received
his undergraduate degree in engineering from the Birla Institute of
Technology and Science in Pilani, India, and both his master’s degree
in public health (Epidemiology) and doctorate in economics from the
University of Washington in Seattle.
His research deals with the integration of epidemiological models
of infectious disease transmission and acquisition of bacterial and
parasite resistance into the economic analysis of public health problems.
His research on “resistance economics” is focussed on improving the
analytical framework to study problems such as bacterial resistance
to antibiotics, and pest resistance to genetically modified crops.
Other research broadly lies at the intersection of environmental quality
and public health. These range from the study of environmental
determinants of infectious disease transmission within households,
to valuing health costs of air and water pollution.
Dr.
Laxminarayan's Homepage
John E. McGowan, M.D.
Professor
Department of Epidemiology
Rollins School of Public Health
Emory University
1518 Clifton Rd, Rm. 442
Atlanta, GA 30322
404-727-9365
404-727-8737 (fax)
jmcgowa@sph.emory.edu
JOHN EDWARD MCGOWAN, JR., M.D.
John McGowan is Professor of Epidemiology, Rollins School of Public
Health of Emory University, Atlanta, Georgia. He also is Professor
of Medicine (Infectious Diseases) and Professor of Pathology and Laboratory
Medicine at Emory University School of Medicine.
He graduated from Dartmouth and Harvard Medical School and trained
at Boston City Hospital, and the Centers for Disease Control and Prevention.
He has been at Emory since 1973. He is Board Certified in Internal
Medicine, Infectious Diseases, and Medical Microbiology. Dr.
McGowan worked from 1973-1998 at Grady Memorial Hospital, Atlanta,
Georgia, where he was an Infectious Diseases Physician, Director of
the Clinical Microbiology Laboratory and Chair of the Infection Control
Service Team.
Dr. McGowan has served on the Governing Boards of the Infectious
Diseases Society of America and the American Society for Microbiology.
He was active in the formation of, and served as first President of,
the Society for Healthcare Epidemiology of America. He has been
associate editor or served on the editorial board of several medical
journals, and has been author or co-author of more than 250 papers,
books, or book chapters in the medical literature.
Martin Meltzer, Ph.D.
Senior Health Economist
Office of Surveillance
Office of the Director
National Center for Infectious Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd.
MS D59
Atlanta, GA 30333
404-371-5353
mmeltzer@cdc.go
Name: Martin I. Meltzer
Position: Senior Health Economist, Office of Surveillance, Office
of the Director, NCID, CDC
Prior Positions: Senior Staff Fellow, OD, NCID, CDC
Education: BSc Agric (Hons) (Zim); MS (Cornell); Ph.D. (Cornell)
Recent Honors/Awards: Charles C. Shepard Award - nominated (2000,
1999); James H. Nakano Citation (2000, 1999); Prevention
Effectiveness Fellowship, CDC.
Editorial Activities: Co-ordinator of economic reviews, The Lancet;
Journal Referee for: Emerging Infectious Diseases; American Journal
of Public Health; Archives of Internal Medicine; Preventive
Veterinary Medicine; Experimental and Applied Acarology; Agriculture
and Human Values; American Journal of Agricultural Economics;
World Development; The Lancet, JAMA, Pharmacoeconomics.
Scientific Interests: Examine the cost-benefit and cost-effectiveness
of various health interventions. Develop strategic plans and formulate
policy guidelines and recommendations for preventive health plans
and the use of health technologies, such as vaccines. "Interface"
between the biological and the social sciences. Analyze empirical
data, using a wide array of statistical and econometric methodologies.
Examples of recent research activities: Economics of vaccinating
restaurant foodhandlers against hepatitis A; Cost-effectiveness of
Lyme disease vaccination; Economic impact of pandemic influenza; Economics
of controlling raccoon rabies using an oral vaccine; Assessing the
global economic impact of dengue; Economics of a bioterrorist attack;
Economic evaluation of switching from DTwP to DTaP vaccine.
Publications: 80 publications, including +50 articles in peer-reviewed
journals, two U.S. patents, software program to aid state and local
public health officials plan for the next influenza pandemic, and
four book chapters.
Maury Mulligan, M.D.
Professor of Medicine and Clinical Scientist
IntraBiotics Pharmaceuticals, Inc.
1255 Terra Bella Avenue
Mountain View, CA 94043
650-567-6632
650-969-0663 (fax)
MMulligan@intrabiotics
Maury L. E. Mulligan, M.D. received her bachelor’s degree from the
University of Hawaii in Honolulu and her medical degree from The Mount
Sinai School of Medicine in New York, NY. After training in
internal medicine at Mount Sinai, she received her infectious diseases
training at the West Los Angeles Veterans Affairs Medical Center and
the University of California Los Angeles with Dr. Sydney Finegold
as her mentor. Dr. Mulligan was Staff Physician for the division
of Infectious Diseases and the AIDS Physician Coordinator at the VA
Medical Center in Long Beach, California and Associate Professor,
Department of Medicine, prior to her position as Hospital Epidemiologist
and Professor of Medicine at the University of Maryland Medical System
in Baltimore. She has been a member of the Academic Senate for
both the University of California at Irvine and the University of
Maryland in Baltimore. Dr. Mulligan has very recently transitioned
to the biotechnology industry by joining IntraBiotics Pharmaceuticals,
Inc. as a Clinical Scientist for the Ramoplanin Vancomycin-Resistant
Enterococcus Program. Dr. Mulligan sits on the editorial board
of Anaerobe, was an associate editor of Clinical Infectious Diseases,
and is a manuscript reviewer for numerous journals including Journal
of the American Medical Association, Journal of Clinical Microbiology,
Journal of Infectious Diseases, and the New England Journal of Medicine.
She has authored nearly 100 peer reviewed journal articles, book chapters,
and reviews. She has had the opportunity to teach in many countries.
Her long term research interests have involved studies of nosocomial
pathogens and bacterial typing.
Randall M. Packard, Ph.D.
Director
Center for the Study of Health,
Culture, and Society
Emory University
1518 Clifton Rd., Rm. 710
Atlanta, GA 30322
404-727-8141
404-727-4590 (fax)
rpackar@sph.emory.edu
Randall M. Packard, Ph.D., is the Asa Griggs Candler Professor of
African History and International Health at Emory University. He holds
a joint appointment in the Rollins School of Public Health and directs
Emory’s Center for the Study of Health, Culture, and Society. His
research focuses on the social history of health, healing and disease
in southern Africa and on the history of international health and
development. His most recent book is White Plague, Black Labor: Tuberculosis
and the Political Economy of Health and Healing in South Africa.
Trish Perl, M.D., MSc
Hospital Epidemiologist
Department of Epidemiology and Infection Control
Johns Hopkins Hospital
600 N Wolfe St.
Osler 425
Baltimore, MD 21287-5425
410-955-8384
410-614-0888 (fax)
TPERL@jhmi.edu
Steven B. Porter, M.D., Ph.D.
Senior Director of Clinical Affairs
IntraBiotics Pharmaceuticals,
Inc
1255 Terra Bella Avenue
Mountain View,CA 94043
415-346-7290
650-969-0663 (fax)
Steven B. Porter, M.D., Ph.D. received his bachelor’s degree from
Davidson College in Davidson, North Carolina, his doctorate of philosophy
in biochemistry from Vanderbilt University, and his doctorate of medicine
from the Vanderbilt University School of Medicine. He completed
his training in internal medicine and infectious diseases at the University
of California, San Francisco, and subsequently was an associate in
the Howard Hughes Institute at Stanford University. Dr. Porter
was previously at Bayer’s Division of Biotechnology where he was in
charge of the anti-TNF monoclonal antibody in septic shock program.
Dr. Porter joined IntraBiotics Pharmaceuticals, Inc. in Mountain View,
California in 1999 as the Senior Director of Clinical Affairs and
is currently responsible for the Clinical Science group. In
addition he is an Assistant Clinical Professor of Medicine at UCSF
and an Attending Physician in the department of Infectious Diseases
at UCSF/San Francisco General Hospital. Dr. Porter has a long-standing
interest in international medicine and has participated in medical
relief programs in a number of countries including Albania, Afghanistan,
Papua New Guinea, and Tanzania.
Sameer Rajbhandary, Ph.D.
Fellow, Prevention Effectiveness
Division of Health Quality Promotion and Infection Prevention
Centers for Disease Control and Prevention
Rebecca Roberts, M.D.
Physician
Cook County Hospital
Department of Emergency Medicine
1900 W. Polk, 10th Floor
Chicago, IL 60612
rroberts@ccbh.org
Mary Claire Roghman, M.D., M.S.
Hospital Epidemiologist
VA Maryland Health Care System
(BT111)
10 N. Greene St.
Baltimore, MD 21201
(410) 605-7394
410-605-7914 (fax)
Mroghman@medicine.umaryland.edu
Mary-Claire Roghmann, M.D., M.S.
Assistant Professor and Head, Division of Health Care Outcomes Research
Department of Epidemiology and Preventive Medicine
University of Maryland School of Medicine
Hospital Epidemiologist, Veterans Administration Maryland Health Care
System.
10 North Greene Street (BT-111)
Baltimore, MD 21201
Research interests:
- epidemiology of antibiotic resistance bacteria
- quality improvement in infection control through the prevention
of nosocomial infections
- quality improvement in the clinical practice of infectious diseases
Education:
Bachelor of Science in Biology: Molecular Genetics
University of Rochester
Rochester, NY 14642
Doctor of Medicine, The Johns Hopkins University School of Medicine
Baltimore, MD 21205
Master of Science, University of Maryland at Baltimore
Department of Preventive Medicine and Epidemiology
Baltimore, MD 21201
Internship, Residency and Chief residency in Internal Medicine University
of Maryland Hospital/Baltimore Veterans Administration Hospital
Fellowship in Infectious Diseases University of Maryland Hospital/Baltimore
Veterans Administration Hospital
Robert Rosenman, Ph.D.
Professor of Economics
Washington State University
Department of Economics
College of Business and Economics
Pullman, Washington 99164-4741
509-335-1193
509-335-4362 (fax)
yamaka@wsu.edu
Robert Rosenman is a Professor and Graduate Program Chair in the
Department of Economics at Washington State University in Pullman.
He received his BA in Economics and Political Science from the University
of Pennsylvania in 1975, and his MA in Economics from the University
of Pennsylvania in 1977, where he did research at the Leonard Davis
Institute of Health Economics. After a brief stint in Washington,
where he consulted on the military health care system, Dr. Rosenman
went to the University of Minnesota where he earned his Ph.D. in 1982.
During his time there, Dr. Rosenman worked at InterStudy, one of the
founding centers for promoting competition in health care. Dr.
Rosenman's doctoral dissertation was in environmental and natural
resource economics, and the first 8 or so years of his professional
career found his research and teaching focused in that area.
He taught at the University of New Hampshire for one year before coming
to WSU in 1982. In 1990 he chaired the Ad Hoc Citizens Committee
for Health Services Assessment for Pullman Memorial Hospital, which
looked into options for Pullman Memorial Hospital, where his interest
in health care economics was rekindled. Since then, his research
has focused on issues in health economics, including how the organization
and characteristics of health maintenance organizations (HMOs) influences
the level of efficiency, productivity and cost analysis, and most
recently the relationship between quality and cost for outpatient
clinics. His current research includes a cost effectiveness
analysis for the PHADE (an artificial heart transplant therapy) study
at Sacred Heart Medical Center in Spokane, WA, and the analysis of
the financial performance of physician practices. Dr. Rosenman
was a trustee of Pullman Memorial Hospital from 1992 to 1999, serving
as Board President from 1993-1997. He has also served on the
Governor's Oversight Subcommittee for HRSA HIV/AIDS Rural Planning
Grant for the State of Washington.
Dr.
Rosenman's Homepage
Sanjay Saint, M.D., M.P.H.
Assistant Professor
Internal Medicine Department
University of Michigan Medical School
Rm. 7E08, 300 NIB, Box 0429
Ann Arbor, MI 48109
734-615-5600
734-615-8341 (Kim)
734-936-8944 (fax)
saint@umich.edu
Kimberly Andrus <kmandrus@med.umich.edu>
Dr. Saint is currently an Assistant Professor of Medicine at the
University of Michigan Medical School. He is a member of the
research faculty in the University of Michigan’s Department of Internal
Medicine and in the Health Services Research & Development Field
Program at the Ann Arbor VA Medical Center. He received his
MD from the UCLA School of Medicine and completed a medical residency
and chief residency at the UCSF School of Medicine. He then went on
to the University of Washington where he completed a two-year clinical
research fellowship in the Robert Wood Johnson Clinical Scholars Program
and concurrently completed the requirement for a Masters in Public
Health from the University of Washington's School of Public Health
in 1998. His research interests have focused on enhancing patient
safety by preventing hospital-acquired complications. He has
published several recent meta-analyses, cost-effectiveness analyses,
and systematic reviews in the areas of catheter-related urinary tract
infection and vascular catheter-related infection, which have appeared
in JAMA, the Archives of Internal Medicine, the American Journal of
Medicine, and the American Journal of Infection Control. He has authored
over 30 peer-reviewed papers and co-authored three clinical manuals,
including the Saint-Frances Guide to Inpatient Medicine. In
addition, he has authored several articles on clinical decision-making
that have appeared in the “Clinical Problem Solving” section of the
New England Journal of Medicine. He has received grant support
for his research from the Department of Veterans Affairs, the APIC
Research Foundation, and the Aetna Quality Care Research Fund.
He has received several research awards; the most recent of which
was the 2000 Blue Cross Blue Shield of Michigan Foundation’s Excellence
in Research Award for Physicians for his study evaluating telephone
management for urinary tract infection in women. He currently
serves on the Board of Trustees of the Research Foundation for the
Prevention of Complications Associated with Health Care, Co-Chairs
the Ann Arbor VA Medical Center’s Adverse Events Committee, and is
a member of the University of Michigan Health System’s Patient Safety
Committee.
R. Douglas Scott, III
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Mailstop: C14
One West Court Square
Decatur ,GA 30030
404-371-5069
404-371-5078 (fax)
zhj2@cdc.gov
Steven L. Solomon, M.D.
National Center for Infectious Diseases, Hospital Infections Program
Centers for Disease Control and Prevention
Executive Park Bldg. 18
Mailstop: A07
Executive Park Dr.
Atlanta, GA 30329
404-639-6476
404-639-6483 (fax)
sls1@cdc.gov
Brett R. South
Senior Research Analyst
Veterans Affairs Capital Network
VISN5
HSR&D Center
10 North Greene St.
Baltimore, MD 21202
brett.south@med.va.gov
Brett R. South, B.S.
Department of Epidemiology and Preventive Medicine,
Division of Healthcare Outcomes Research,
University of Maryland at Baltimore, School of Medicine
and
Senior Research Analyst, Veterans Affairs Capital Network (VISN
5) HSR&D Center
Brett R. South received a Bachelor’s degree in biology and political
science from Utah State University in 1995. He has worked in
the analytical support of health policy, focusing on the development
of analytic tools to examine health care utilization and expenses.
South is engaged in several studies of health care outcomes and cost
savings associated with new interventions in health promotion, peripheral
arterial disease, congestive heart failure, obesity, diabetes and
home and community health care. He is currently the senior research
analyst at the Veterans Affairs Capital Network Health Services Research
and Development Center in Baltimore, Maryland. His graduate
work focuses on health policy analysis for public sector health care
financing.
James P. Steinberg, M.D.
Associate Professor and Acting Chief of Medicine
Department of Medicine
Infectious Diseases
Emory University Hospital
Dr. James Steinberg is Associate Professor of Medicine in the Division
of Infectious Diseases at Emory University School of Medicine.
He is also Acting Chief of Medicine, Chief of Infectious Diseases,
and Hospital Epidemiologist at Crawford Long Hospital of Emory University.
Dr. Steinberg is originally from Omaha, Nebraska and attended Cornell
University and the University of Nebraska School of Medicine. He completed
his medical residency at Emory University and his infectious diseases
fellowship at Northwestern University. He is the past president
of the Infectious Diseases Society of Georgia.
Steven Teutsch, M.D., M.P.H.
Senior Director
Outcomes Research and Management
Merck & Co., Inc.
P.O. Box 4, WP39-169
Sumneytown Pike and Broad Street
West Point, PA 19486-0004
215-652-2788
215-652-0860 (fax)
steven_teutsch@merck.com
Kathy Winder <kathryn_winder@merck.com>
Steven M. Teutsch became Senior Director, Outcomes Research and Management
in October 1997 where he is responsible for scientific leadership
in developing evidence-based clinical management programs, conducting
outcomes research studies, and improving outcomes measurement to enhance
quality of care. Prior to joining Merck he was Director of the
Division of Prevention Research and Analytic Methods (DPRAM) at CDC
where he was responsible for assessing the effectiveness, safety,
and the cost-effectiveness of disease and injury prevention strategies.
DPRAM developed comparable methodology for studies of the effectiveness
and economic impact of prevention programs, provided training in these
methods, developed CDC’s capacity for conducting necessary studies,
and provided technical assistance for conducting economic and decision
analysis. The Division also evaluated the impact of interventions
in urban areas, is developing a Guide to Community Health Services,
and provides support for CDC’s analytic methods. He currently serves
as a consultant to that project and is also a member of the U.S. Preventive
Services Task Force which develops the Guide to Clinical Preventive
Srevices. He serves as consultant to the Robert Wood Johnson
Foundation Program on Population Health.
Dr. Teutsch came to CDC in 1977, where he was assigned to the Parasitic
Diseases Division and worked extensively on toxoplasmosis. He
was then assigned to the Kidney Donor and subsequently the Kidney
Disease Program. He developed the framework for CDC's diabetes
control program. He joined the Epidemiology Program Office and
became the Director of the Division of Surveillance and Epidemiology
where he was responsible for CDC's disease monitoring activities.
He became Chief of the Prevention Effectiveness Activity in 1992.
Dr. Teutsch was born June 25, 1948, in Salt Lake City, Utah.
He received his undergraduate degree in biochemical sciences at Harvard
University in 1970, an M.P.H. in epidemiology from the University
of North Carolina School of Public Health in 1973, and his M.D. from
Duke University School of Medicine in 1974. He completed his
residency training in internal medicine at Pennsylvania State University,
Hershey. He was certified by the American Board of Internal
Medicine in 1977, the American Board of Preventive Medicine in 1995,
and is a Fellow of the American College of Physicians. Dr. Teutsch
is an Adjunct Professor at the Emory University School of Public Health,
Department of Health Policy and Management, U.No. Carolina School
of Public Health and Senior Scholar at U. Pennsylvania.
Dr. Teutsch has published over 90 articles and 5 books in a broad
range of fields in epidemiology, including parasitic diseases, diabetes,
technology assessment, health services research, and surveillance.
J. Todd Weber, M.D., FACP
Senior Medical Officer
National Center for Infectious Diseases
Centers for Disease Control and Prevention
Mailstop C-12
1600 Clifton Road NE
Atlanta, GA 30333
404-639-2603
404-639-4197
jtw5@cdc.gov
Dr. Weber is a Senior Medical Officer in the Office of the Director,
National Center for Infectious Diseases, CDC. He works on antimicrobial
resistance activities coordination and policy. During his 10
years at CDC,
he has worked in the Division of Bacterial and Mycotic Diseases, the
Division of Sexually Transmitted Diseases and HIV Prevention, and
the Division of HIV/AIDS Prevention. He has also worked in the
White House
Office of National AIDS Policy and is an attending physician at the
Atlanta Veterans Affairs Medical Center.
Robert A. Weinstein, M.D.
Chairman
Division of Infectious Diseases
Cook County Hospital
1835 W. Harrison St., Suite 129
Chicago, IL 60612
312-633-6000(Diane Patton)
312-572-3523 (fax)
Diane Patton <generalp12@aol.com>
Robert A. Weinstein, M.D. is Chairman, Division of Infectious Diseases,
Cook County Hospital and Cook County Bureau of Health Services.
He is Professor of Medicine at Rush Medical College. He is an
internationally recognized and extensively published hospital epidemiologist
and infectious disease expert. His major areas of research
include control and prevention of antibiotic resistant bacteria in
hospitals, the epidemiology and control of infections in Intensive
Care Units, and health outcomes in patients with HIV/AIDS. He
was the President of the Society for Healthcare Epidemiology of America,
is the Chair of the American Hospital Association's Technical Panel
on Infections within Hospitals, and is the current chair of the Centers
for Disease Control and Prevention Healthcare Infection Control
Practices Advisory Committee.
